HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Various isoforms of 17-β-hydroxysteroid dehydrogenase, namely HSD17B13, have previously been found to be associated with non-alcoholic fatty liver disease and HCC recurrence and progression [55,56].